ITeos Therapeutics Inc

NASDAQ:ITOS   3:59:59 PM EDT
16.94
+0.02 (+0.12%)
Earnings Announcements

iTeos Reports First Quarter 2022 Financial Results

Published: 05/12/2022 20:59 GMT
ITeos Therapeutics Inc (ITOS) - Iteos Reports First Quarter 2022 Financial Results and Provides Business Update.
Iteos Therapeutics Inc - Cash Balance of $824.0mm As of March 31, 2022, Providing Runway Into 2026.
Iteos Therapeutics - Net Income of $1.82 per Diluted Share, for Quarter Ended March 31, 2022.
Revenue is expected to be $85.56 Million
Adjusted EPS is expected to be $1.23

Next Quarter Revenue Guidance is expected to be $60.02 Million
Next Quarter EPS Guidance is expected to be $0.59

More details on our Analysts Page.